{"context":{"query":">>efo>>gwas","source_dataset":"efo","target_dataset":"gwas"},"stats":{"queried":1,"total":100,"mapped":1},"pagination":{"has_next":true,"next_token":"-1[]EFO:0000389,72,EFO:0000389,144,0]["},"schema":"id|disease_trait|mapped_gene|chr_id|p_value","mappings":[{"input":"EFO:0000389","source":"EFO:0000389|cutaneous melanoma","targets":["GCST003061_1|Cutaneous malignant melanoma|RMDN2, RMDN2-AS1|2|7.000000e-09","GCST003061_10|Cutaneous malignant melanoma|GPR37|7|5.000000e-07","GCST003061_11|Cutaneous malignant melanoma|LINC-PINT|7|4.000000e-07","GCST003061_12|Cutaneous malignant melanoma|RNA5SP293 - RPS15AP27|9|6.000000e-07","GCST003061_13|Cutaneous malignant melanoma|TPCN2 - SMIM38|11|3.000000e-07","GCST003061_14|Cutaneous malignant melanoma|GPRC5A - GPRC5D-AS1|12|3.000000e-07","GCST003061_15|Cutaneous malignant melanoma|CDH1|16|3.000000e-07","GCST003061_16|Cutaneous malignant melanoma|MHENCR - STMN3|20|1.000000e-06","GCST003061_2|Cutaneous malignant melanoma|CDKAL1|6|4.000000e-08","GCST003061_3|Cutaneous malignant melanoma|AHR|7|7.000000e-09","GCST003061_4|Cutaneous malignant melanoma|LINC01505|9|7.000000e-11","GCST003061_5|Cutaneous malignant melanoma|STN1|10|2.000000e-09","GCST003061_6|Cutaneous malignant melanoma|LINC01488 - PNCRNA-D|11|2.000000e-12","GCST003061_7|Cutaneous malignant melanoma|OCA2|15|2.000000e-11","GCST003061_8|Cutaneous malignant melanoma|WDPCP|2|1.000000e-06","GCST003061_9|Cutaneous malignant melanoma|RNU6-637P - TERC|3|3.000000e-07","GCST007505_1|Nevus count or cutaneous melanoma|RNA5SP293 - RPS15AP27|9|2.000000e-14","GCST007505_10|Nevus count or cutaneous melanoma|AHR|7|1.000000e-09","GCST007505_11|Nevus count or cutaneous melanoma|GPRC5A|12|3.000000e-11","GCST007505_12|Nevus count or cutaneous melanoma|TTC7B|14|4.000000e-07","GCST007505_13|Nevus count or cutaneous melanoma|PLA2G6|22|3.000000e-23","GCST007505_14|Nevus count or cutaneous melanoma|SYNE2|14|4.000000e-08","GCST007505_15|Nevus count or cutaneous melanoma|PPARGC1B|5|2.000000e-09","GCST007505_16|Nevus count or cutaneous melanoma|PARP1 - RPS3AP7|1|1.000000e-11","GCST007505_17|Nevus count or cutaneous melanoma|NFIC|19|3.000000e-08","GCST007505_18|Nevus count or cutaneous melanoma|CLPTM1L|5|3.000000e-14","GCST007505_19|Nevus count or cutaneous melanoma|MX2|21|4.000000e-10","GCST007505_2|Nevus count or cutaneous melanoma|TYR|11|2.000000e-11","GCST007505_20|Nevus count or cutaneous melanoma|TASOR2|10|2.000000e-08","GCST007505_21|Nevus count or cutaneous melanoma|CYP1B1, CYP1B1-AS1|2|1.000000e-10","GCST007505_22|Nevus count or cutaneous melanoma|LINC01488 - PNCRNA-D|11|1.000000e-06","GCST007505_23|Nevus count or cutaneous melanoma|HDAC4|2|1.000000e-09","GCST007505_24|Nevus count or cutaneous melanoma|PIGU|20|5.000000e-13","GCST007505_25|Nevus count or cutaneous melanoma|DOCK8|9|1.000000e-12","GCST007505_26|Nevus count or cutaneous melanoma|ARNT|1|2.000000e-10","GCST007505_27|Nevus count or cutaneous melanoma|C11orf65, ATM|11|8.000000e-11","GCST007505_28|Nevus count or cutaneous melanoma|FANCA|16|2.000000e-45","GCST007505_29|Nevus count or cutaneous melanoma|CASP8, FLACC1|2|4.000000e-06","GCST007505_3|Nevus count or cutaneous melanoma|GPRC5A|12|1.000000e-09","GCST007505_30|Nevus count or cutaneous melanoma|MTAP|9|7.000000e-67","GCST007505_4|Nevus count or cutaneous melanoma|MTAP|9|2.000000e-34","GCST007505_5|Nevus count or cutaneous melanoma|FMN1|15|1.000000e-10","GCST007505_6|Nevus count or cutaneous melanoma|FTO|16|2.000000e-08","GCST007505_7|Nevus count or cutaneous melanoma|RNU6-637P - TERC|3|8.000000e-10","GCST007505_8|Nevus count or cutaneous melanoma|PLA2G6|22|2.000000e-28","GCST007505_9|Nevus count or cutaneous melanoma|LINC01505|9|2.000000e-10","GCST010152_1|Neuroblastoma or malignant cutaneous melanoma|LINC02780|1|4.000000e-08","GCST010152_10|Neuroblastoma or malignant cutaneous melanoma|UGT1A8, UGT1A6, UGT1A7, UGT1A9, UGT1A10|2|6.000000e-08","GCST010152_11|Neuroblastoma or malignant cutaneous melanoma|ARHGAP24|4|1.000000e-07","GCST010152_12|Neuroblastoma or malignant cutaneous melanoma|ANXA9|1|2.000000e-08","GCST010152_13|Neuroblastoma or malignant cutaneous melanoma|STN1 - SLK|10|6.000000e-10","GCST010152_14|Neuroblastoma or malignant cutaneous melanoma|SPIRE2|16|1.000000e-12","GCST010152_15|Neuroblastoma or malignant cutaneous melanoma|HLA-DRB1 - HLA-DQA1|6|2.000000e-06","GCST010152_16|Neuroblastoma or malignant cutaneous melanoma|AQP3 - NOL6|9|3.000000e-07","GCST010152_2|Neuroblastoma or malignant cutaneous melanoma|MAGI3|1|5.000000e-08","GCST010152_3|Neuroblastoma or malignant cutaneous melanoma|EEF1AKMT1 - XPO4|13|2.000000e-06","GCST010152_4|Neuroblastoma or malignant cutaneous melanoma|ACSL1|4|5.000000e-06","GCST010152_5|Neuroblastoma or malignant cutaneous melanoma|DLGAP4|20|6.000000e-06","GCST010152_6|Neuroblastoma or malignant cutaneous melanoma|Y_RNA - SMLR1|6|9.000000e-06","GCST010152_7|Neuroblastoma or malignant cutaneous melanoma|HSD17B12|11|4.000000e-07","GCST010152_8|Neuroblastoma or malignant cutaneous melanoma|SNX29 - CPPED1|16|9.000000e-07","GCST010152_9|Neuroblastoma or malignant cutaneous melanoma|CHODL|21|7.000000e-07","GCST010302_1|Cutaneous melanoma or hair colour|SLC45A2|5|0.000000e+00","GCST010302_10|Cutaneous melanoma or hair colour|DSTYK|1|2.000000e-82","GCST010302_11|Cutaneous melanoma or hair colour|LINC-PINT|7|1.000000e-76","GCST010302_12|Cutaneous melanoma or hair colour|ZNG1A - DOCK8-AS1|9|1.000000e-43","GCST010302_13|Cutaneous melanoma or hair colour|AKAP12|6|2.000000e-42","GCST010302_14|Cutaneous melanoma or hair colour|PPFIBP2|11|2.000000e-33","GCST010302_15|Cutaneous melanoma or hair colour|AHNAK|11|2.000000e-33","GCST010302_16|Cutaneous melanoma or hair colour|SAMMSON|3|2.000000e-32","GCST010302_17|Cutaneous melanoma or hair colour|SYNE2|14|6.000000e-27","GCST010302_18|Cutaneous melanoma or hair colour|LINC01505|9|7.000000e-27","GCST010302_19|Cutaneous melanoma or hair colour|CLPTM1L|5|5.000000e-24","GCST010302_2|Cutaneous melanoma or hair colour|HERC2|15|0.000000e+00","GCST010302_20|Cutaneous melanoma or hair colour|C5orf67 - MAP3K1|5|3.000000e-22","GCST010302_21|Cutaneous melanoma or hair colour|PLXNB2|22|2.000000e-19","GCST010302_22|Cutaneous melanoma or hair colour|RNU6-921P - ZFP36L1|14|2.000000e-19","GCST010302_23|Cutaneous melanoma or hair colour|CDKN2B-AS1|9|2.000000e-18","GCST010302_24|Cutaneous melanoma or hair colour|MED13L|12|5.000000e-17","GCST010302_25|Cutaneous melanoma or hair colour|MARK3|14|1.000000e-16","GCST010302_26|Cutaneous melanoma or hair colour|PTPN14|1|2.000000e-13","GCST010302_27|Cutaneous melanoma or hair colour|TMEM163|2|7.000000e-13","GCST010302_28|Cutaneous melanoma or hair colour|GIPC2, DNAJB4|1|2.000000e-12","GCST010302_29|Cutaneous melanoma or hair colour|NIPAL3|1|2.000000e-12","GCST010302_3|Cutaneous melanoma or hair colour|SPG7|16|3.000000e-262","GCST010302_30|Cutaneous melanoma or hair colour|KIAA0930 - UPK3A|22|3.000000e-12","GCST010302_31|Cutaneous melanoma or hair colour|C13orf46 - RASA3|13|5.000000e-12","GCST010302_32|Cutaneous melanoma or hair colour|ADD3|10|3.000000e-11","GCST010302_33|Cutaneous melanoma or hair colour|LINC01953 - SPAG16-DT|2|1.000000e-10","GCST010302_34|Cutaneous melanoma or hair colour|TMEM170B - Metazoa_SRP|6|1.000000e-10","GCST010302_35|Cutaneous melanoma or hair colour|LINC02756 - TUBB4BP4|11|6.000000e-10","GCST010302_36|Cutaneous melanoma or hair colour|RREB1|6|8.000000e-10","GCST010302_37|Cutaneous melanoma or hair colour|LINC01491 - SLC24A5|15|1.000000e-09","GCST010302_38|Cutaneous melanoma or hair colour|LMO7|13|9.000000e-09","GCST010302_39|Cutaneous melanoma or hair colour|CDH3|16|1.000000e-08","GCST010302_4|Cutaneous melanoma or hair colour|PIGU|20|0.000000e+00","GCST010302_40|Cutaneous melanoma or hair colour|DNMT3A - ARNILA|2|1.000000e-08","GCST010302_41|Cutaneous melanoma or hair colour|LRRN2|1|1.000000e-08","GCST010302_42|Cutaneous melanoma or hair colour|ATP10A|15|2.000000e-08","GCST010302_43|Cutaneous melanoma or hair colour|FTO|16|3.000000e-08"]}]}